Pages that link to "Q33496712"
Jump to navigation
Jump to search
The following pages link to NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness (Q33496712):
Displaying 50 items.
- Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits (Q26830533) (← links)
- Following the genes: a framework for animal modeling of psychiatric disorders (Q26830603) (← links)
- The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia (Q27023087) (← links)
- Neuromagnetic oscillations predict evoked-response latency delays and core language deficits in autism spectrum disorders (Q27316338) (← links)
- Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex (Q27332387) (← links)
- Phencyclidine Disrupts the Auditory Steady State Response in Rats (Q28547137) (← links)
- The auditory steady-state response (ASSR): a translational biomarker for schizophrenia. (Q30378324) (← links)
- Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine. (Q30383064) (← links)
- Effects of NMDA and GABA-A Receptor Antagonism on Auditory Steady-State Synchronization in Awake Behaving Rats (Q30403781) (← links)
- Brain state-dependent abnormal LFP activity in the auditory cortex of a schizophrenia mouse model (Q30435025) (← links)
- How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia (Q30439924) (← links)
- Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations (Q30453949) (← links)
- Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia (Q30455798) (← links)
- Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power (Q30466734) (← links)
- A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. (Q30468321) (← links)
- Ketamine alters oscillatory coupling in the hippocampus (Q30542045) (← links)
- Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. (Q30586288) (← links)
- A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway (Q33607904) (← links)
- Temporal dynamics of distinct CA1 cell populations during unconscious state induced by ketamine (Q33774223) (← links)
- Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. (Q33819365) (← links)
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects (Q34333515) (← links)
- Alpha and gamma oscillations characterize feedback and feedforward processing in monkey visual cortex (Q34407518) (← links)
- Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia (Q34583614) (← links)
- Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis (Q34996731) (← links)
- Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia (Q35613651) (← links)
- Electroencephalographic coherence and cortical acetylcholine during ketamine-induced unconsciousness (Q35622231) (← links)
- Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse (Q35624356) (← links)
- Baseline gamma power during auditory steady-state stimulation in schizophrenia (Q35702202) (← links)
- Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings (Q35950825) (← links)
- State-dependent increase of cortical gamma activity during REM sleep after selective blockade of NR2B subunit containing NMDA receptors. (Q36013834) (← links)
- Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens (Q36083621) (← links)
- NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia (Q36245009) (← links)
- DNA microarray unravels rapid changes in transcriptome of MK-801 treated rat brain. (Q36310447) (← links)
- Effects of memantine on event-related potential, oscillations, and complexity in individuals with and without family histories of alcoholism. (Q36597555) (← links)
- Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations (Q36678412) (← links)
- Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans (Q36821450) (← links)
- Chronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivo (Q37177032) (← links)
- Decreased haemodynamic response and decoupling of cortical gamma-band activity and tissue oxygen perfusion after striatal interleukin-1 injection (Q37203598) (← links)
- Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice (Q37235864) (← links)
- Sensory encoding in Neuregulin 1 mutants (Q37292555) (← links)
- Metabotropic glutamate receptor 5 negative modulation in phase I clinical trial: potential impact of circadian rhythm on the neuropsychiatric adverse reactions-do hallucinations matter? (Q37651104) (← links)
- Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia (Q37846896) (← links)
- Transcranial magnetic stimulation on the modulation of gamma oscillations in schizophrenia. (Q38028607) (← links)
- A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo (Q38122300) (← links)
- Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia (Q38568415) (← links)
- Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats (Q38766481) (← links)
- Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy (Q39646371) (← links)
- Fast oscillatory activity induced by kainate receptor activation in the rat basolateral amygdala in vitro. (Q39868909) (← links)
- 40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors (Q40031007) (← links)
- Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice (Q40773725) (← links)